Methylation-Based Classification of Cervical Squamous Cell Carcinoma into Two New Subclasses Differing in...

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Cervical cancer has two main histological subtypes: squamous cell carcinoma (CSCC) and adenocarcinoma (CA).
• Existing classifications may not fully capture the molecular heterogeneity within these subtypes.
• Understanding molecular differences is crucial for personalized treatment strategies.

Purpose of the Study:

• To identify novel molecular subclasses within cervical cancer using methylation data.
• To investigate the immune microenvironment differences between these subclasses.
• To correlate molecular features with patient survival and neo-epitope burden.

Main Methods:

• Applied consensus clustering to 307 cervical cancer methylation samples from The Cancer Genome Atlas (TCGA).
• Performed transcription factor (TF) and genomic region enrichment analysis using Fisher's exact test.
• Analyzed gene expression, immune cell infiltration, and predicted neo-epitopes.

Main Results:

• Identified three subclasses: Class 1 (adenocarcinoma) and Classes 2 & 3 (dividing CSCC).
• Class 3 (CSCC) showed promoter hypomethylation enriched in immune pathway-related TFs and genes.
• Class 3 exhibited higher immune cell infiltration, increased immune genes, and correlated with better survival and neo-epitope burden.

Conclusions:

• Established a new classification for the CSCC subtype into two distinct molecular subclasses.
• These subclasses differ significantly in immune gene expression and immune cell infiltration.
• Findings highlight the role of the immune microenvironment in CSCC heterogeneity and patient outcomes.